AI aims to predict lung health drops before they happen
NCT ID NCT07419555
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a machine learning model that uses past lung function tests to predict future changes in 4,000 adults with chronic respiratory diseases. Researchers will check if the model's predictions match real outcomes like hospital visits and health status. The goal is to help doctors catch problems earlier and tailor care to each patient.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors spot early signs of worsening lung disease and personalize treatment plans.
- What could go wrong
- This is an observational study, not a treatment trial. The model may not accurately predict outcomes for all patients, and results may not apply beyond the study group.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 4,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2026
- Expected to finish
-
Mar 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Chronic respiratory diseases
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Above 18 years old * Diagnosed with a chronic respiratory disease and followed up in one of the participating Belgian hospitals * Performed a complete lung function test (spirometry, body plethysmography and diffusion capacity) at baseline * Have at least 3 historical spirometry measurements over a minimal time window of 2 years prior to inclusion * Planned routine follow-up within standard clinical care in one of the participating hospitals Exclusion Criteria: * Patients who have had a lung transplantation * Patients not being able to give consent to participate
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic respiratory diseases are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
4 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
AZ Delta
NOT_YET_RECRUITINGRoeselare, 8800, Belgium
-
UZ Antwerpen
NOT_YET_RECRUITINGEdegem, 2650, Belgium
-
UZ Leuven
RECRUITINGLeuven, 3000, Belgium
-
Ziekenhuis Oost-Limburg
NOT_YET_RECRUITINGGenk, 3600, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Video game breathing: a new hope for Kids' lungs?
- Can a drop of blood predict disease years before it strikes?
- Digital app may bring lung rehab to local clinics
- Handheld breath test could spot lung disease early
- How strong should you be? new study aims to find out
- Massive 10-Year health check: what happens when chronic diseases collide?